Higher levelsof ESRP1, and a higher ratio of ESRP1/HAS2 and ESRP1/ZEB1, correlate with poorrelapse-free survival (RFS) and overall survival (OS) in multiple independentbreast cancer datasets [Figs. 5(a)–5(c) and S5]. Here, HAS2 is linked to cancer.